Nuwellis (NASDAQ:NUWE) Releases Earnings Results, Misses Estimates By $0.24 EPS

Nuwellis (NASDAQ:NUWE) posted its quarterly earnings data on Tuesday. The company reported ($0.69) EPS for the quarter, missing analysts’ consensus estimates of ($0.45) by ($0.24), Zacks reports. Nuwellis had a negative net margin of 169.54% and a negative return on equity of 28,159.25%.

Nuwellis Price Performance

NASDAQ NUWE opened at $1.00 on Wednesday. Nuwellis has a 12 month low of $0.75 and a 12 month high of $11.66. The company has a 50-day moving average of $0.99 and a 200-day moving average of $1.21. The company has a market cap of $4.37 million, a P/E ratio of -0.01 and a beta of 0.51.

Nuwellis Company Profile

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.